Dr. Raj Chovatiya, MD, PhD | Dr. Matthew Zirwas, MD | Douglas DiRuggiero, DMSc, PA-C
November 9th, 2023
What's new in systemic therapies for atopic dermatitis, AKA eczema, and should we be concerned about those scary black box warnings...?
Dr. Matthew Zirwas is featured at this year's Maui Derm Conference giving his expert opinion on all that is new and cool regarding the JAK-inhibitors used in dermatology.
Thanks JCAD TV!
"IF WE'RE NOT TRYING TO GET OUR PATIENTS ON NONSTEROIDALS AND THEY'RE USING TOPICAL STEROIDS CHRONICALLY, WE'RE DOING THEM A DISSERVICE. "
-Dr. Matthew Zirwas
Matthew Zirwas, MD - WHAT ARE SOME COMMON TRIGGERS FOR WORSENING OF ATOPIC DERMATITIS?
Matthew Zirwas, MD - WHAT OTHER TOPICAL MEDICATIONS WITH NOVEL MECHANISMS OF ACTION ARE IN THE PIPELINE FOR ATOPIC DERMATITIS?
Matthew Zirwas, MD - WHY DO PATIENTS WITH ATOPIC DERMATITIS SOMETIMES SUDDENLY GET WORSE?
Dr. Matthew Zirwas | Contact Dermatitis and AD
Matthew Zirwas, MD - DOES ATOPIC DERMATITIS ALWAYS START IN CHILDHOOD?
Matthew Zirwas, MD - DO PEOPLE WITH ATOPIC DERMATITIS ALWAYS HAVE ATOPIC CO-MORBIDITIES?
Matthew Zirwas, MD - HOW CONCERNED ARE YOU ABOUT THE RISK OF THROMBOSIS MENTIONED IN THE BOXED WARNING FOR RUXOLITINIB CREAM?
Effective management of sometimes-debilitating itch starts with understanding type. Matthew J. Zirwas, MD, offered tips for diagnosing and treating widespread itch with little or no rash as part of his presentation at the recent New Wave Dermatology Conference
Matthew Zirwas, MD - IS THERE ANY DATA ON CONTACT DERMATITIS WITH USE OF TOPICAL JAK INHIBITORS FOR ATOPIC DERMATITIS?
Matthew Zirwas, MD - CAN PREGNANT PATIENTS USE RUXOLITINIB CREAM?
Matthew Zirwas, MD - HOW DO YOU MAKE THE DIAGNOSIS OF ATOPIC DERMATITIS?
A RARE TYPE OF DERMATOLOGIST WHO PRACTICES DIFFERENTLY - The Eczema Podcast (S4E02)
Matthew Zirwas, MD - HOW CONCERNED ARE YOU ABOUT THE RISK OF DEATH MENTIONED IN THE BOXED WARNING FOR RUXOLITINIB CREAM?
Matthew Zirwas, MD - HOW COMMON IS ATOPIC DERMATITIS COMPARED TO PSORIASIS?
Matthew Zirwas, MD - WHAT ARE THE ADVANTAGES OF JAK THERAPY VS. MONOCLONAL ANTIBODY THERAPY FOR ATOPIC DERMATITIS?
Matthew Zirwas, MD - HOW CONCERNED ARE YOU ABOUT THE RISK OF INFECTION MENTIONED IN THE RISK OF INFECTION MENTIONED IN THE BOXED WARNING?
Matthew Zirwas, MD - IS THERE ANYTHING NEW KNOWN ABOUT THE ATOPIC MARCH?
Matthew Zirwas, MD - DOES ATOPIC DERMATITIS ALWAYS INVOLVE THE FLEXURAL AREAS?
We value your feedback!